These findings not only elucidate the underlying role of TRIM56 in driving migration and proliferation of glioma cells in vitro and in vivo, but may also provide a theoretical basis for the use of TRIM56 in the diagnosis and treatment of glioma. Here, TRIM56 is linked to central nervous system cancer.